Patients with AML who achieve long term complete remission do not have a normal life expectancy when compared to the general population. Analysis of 3,012 patients enrolled on 9 consecutive ECOG-ACRIN trials Meeting Abstract
| Authors: | Ganzel, C.; Roopcharan, K.; Sun, Z.; Rowe, J. M.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; Douer, D.; Wiernik, P. H.; Tallman, M. S.; Litzow, M. R. |
| Abstract Title: | Patients with AML who achieve long term complete remission do not have a normal life expectancy when compared to the general population. Analysis of 3,012 patients enrolled on 9 consecutive ECOG-ACRIN trials |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398802229 |
| DOI: | 10.1182/blood-2021-149208 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 690 -- Hybrid meeting, also took place online -- Source: Wos |
